AcelRx Pharmaceuticals, Inc. (ACRX):企業の財務及び戦略的SWOT分析

◆英語タイトル:AcelRx Pharmaceuticals, Inc. (ACRX) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single UserUSD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム



AcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that develops therapies. The company develops and markets therapies for the treatment of acute and breakthrough pain. Its product pipeline includes Zalviso, ARX-02, ARX-03 and ARX-04. AcelRx’s Zalviso has completed Phase 3 development. The company’s products in cancer breakthrough pain, procedural sedation, and acute trauma pain have completed Phase 2 studies. It offers therapies for painful conditions caused due to side effects of morphine, the invasive IV route of delivery and the inherent potential for programming. The company provides products in non-invasive sublingual dosage form. AcelRx is headquartered in Redwood, California, the US.

AcelRx Pharmaceuticals, Inc. Key Recent Developments

Oct 29, 2015: AcelRx Pharmaceuticals Provides Business Update and Reports Third Quarter and Nine Months 2015 Financial Results
Oct 01, 2015: AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial Strategy
Aug 03, 2015: AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results
May 04, 2015: AcelRx Pharmaceuticals Reports First Quarter 2015 Financial Results
Apr 14, 2015: AcelRx Pharmaceuticals Announces Presentation Of Sublingual Sufentanil Data At The Society of American Gastrointestinal and Endoscopic Surgeons Meeting

This comprehensive SWOT profile of AcelRx Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of AcelRx Pharmaceuticals, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

AcelRx Pharmaceuticals, Inc. – Key Information
AcelRx Pharmaceuticals, Inc. – Overview
AcelRx Pharmaceuticals, Inc. – Key Employees
AcelRx Pharmaceuticals, Inc. – Key Employee Biographies
AcelRx Pharmaceuticals, Inc. – Key Operational Heads
AcelRx Pharmaceuticals, Inc. – Major Products and Services
AcelRx Pharmaceuticals, Inc. – History
AcelRx Pharmaceuticals, Inc. – Company Statement
AcelRx Pharmaceuticals, Inc. – Locations And Subsidiaries
AcelRx Pharmaceuticals, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

AcelRx Pharmaceuticals, Inc. – Business Description
AcelRx Pharmaceuticals, Inc. – Corporate Strategy
AcelRx Pharmaceuticals, Inc. – SWOT Analysis
SWOT Analysis – Overview
AcelRx Pharmaceuticals, Inc. – Strengths
AcelRx Pharmaceuticals, Inc. – Weaknesses
AcelRx Pharmaceuticals, Inc. – Opportunities
AcelRx Pharmaceuticals, Inc. – Threats
AcelRx Pharmaceuticals, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

AcelRx Pharmaceuticals, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

AcelRx Pharmaceuticals, Inc., Key Information
AcelRx Pharmaceuticals, Inc., Key Ratios
AcelRx Pharmaceuticals, Inc., Share Data
AcelRx Pharmaceuticals, Inc., Major Products and Services
AcelRx Pharmaceuticals, Inc., History
AcelRx Pharmaceuticals, Inc., Key Employees
AcelRx Pharmaceuticals, Inc., Key Employee Biographies
AcelRx Pharmaceuticals, Inc., Key Operational Heads
AcelRx Pharmaceuticals, Inc., Other Locations
AcelRx Pharmaceuticals, Inc., Subsidiaries
AcelRx Pharmaceuticals, Inc., Key Manufacturing facilities
AcelRx Pharmaceuticals, Inc., Key Competitors
AcelRx Pharmaceuticals, Inc., SWOT Analysis
AcelRx Pharmaceuticals, Inc., Ratios based on current share price
AcelRx Pharmaceuticals, Inc., Annual Ratios
AcelRx Pharmaceuticals, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

AcelRx Pharmaceuticals, Inc., Performance Chart
AcelRx Pharmaceuticals, Inc., Ratio Charts


★リサーチレポート[ AcelRx Pharmaceuticals, Inc. (ACRX):企業の財務及び戦略的SWOT分析(AcelRx Pharmaceuticals, Inc. (ACRX) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。